Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

18 trials with published results (14%)

Research Maturity

86 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.4%

3 terminated out of 127 trials

Success Rate

96.6%

+10.1% vs benchmark

Late-Stage Pipeline

3%

4 trials in Phase 3/4

Results Transparency

21%

18 of 86 completed with results

Key Signals

18 with results97% success

Data Visualizations

Phase Distribution

123Total
Not Applicable (110)
Early P 1 (3)
P 1 (2)
P 2 (4)
P 3 (1)
P 4 (3)

Trial Status

Completed86
Unknown18
Recruiting8
Active Not Recruiting5
Not Yet Recruiting4
Terminated3

Trial Success Rate

96.6%

Benchmark: 86.5%

Based on 86 completed trials

Clinical Trials (127)

Showing 20 of 20 trials
NCT07331181Not ApplicableRecruitingPrimary

Evaluation of Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles

NCT03228641Not ApplicableCompletedPrimary

Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity

NCT07421544Phase 4Not Yet Recruiting

Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

NCT06336044Not ApplicableRecruitingPrimary

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

NCT04577898Not ApplicableCompleted

RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows

NCT06351293Not ApplicableCompletedPrimary

A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction

NCT07187297Not ApplicableRecruitingPrimary

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

NCT07118943Not ApplicableCompleted

Efficacy of Four Topical Products to Improve Skin Longevity

NCT07221461Phase 2Not Yet RecruitingPrimary

Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

NCT06645366Not ApplicableCompletedPrimary

Device for Improving Skin Quality and Texture on the Face and Neck

NCT06157567Not ApplicableActive Not Recruiting

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

NCT06202274Not ApplicableActive Not Recruiting

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

NCT04717934Not ApplicableCompletedPrimary

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

NCT06366503Not ApplicableCompleted

Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation

NCT06932770Not ApplicableCompleted

Anti-aging Efficacy of Food Supplement and Cosmetic Routine

NCT04595331Not ApplicableCompleted

Open Label Extension for 43USSA1812

NCT06726122Not ApplicableEnrolling By Invitation

Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment

NCT06104514Not ApplicableCompleted

Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids

NCT04540900Phase 1Active Not Recruiting

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

NCT06868615Not ApplicableRecruiting

AVAVA MIRIA General Use

Scroll to load more

Research Network

Activity Timeline